Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

VICC toll-free number 1-877-936-8422

Head and Neck Cancers

Although head and neck cancer is a common malignancy, there are few programs in the country that have dedicated, multidisciplinary teams to treat a large number of patients. The Vanderbilt-Ingram Cancer Center has a nationally recognized Head and Neck Cancer Program which is staffed by expert surgeons, a full-time medical oncologist and full-time radiation oncologists.

Clinical Trials for Head and Neck Cancers

14 Open Trials

Trial Type Protocol No. &
Open Date
Summary

Basic Science

VICCHN0603

04/28/2006

Effect of PI3K Inhibition in HPV Infected Cell (deidentified)

Basic Science

VICCHN0529

05/10/2005

Novel Protein Regulator of Tumor Suppressor ARF & NF-kB (NIH/2 R01 DEO13173-05) (deidentified)

Basic Science

VICCHN0530

04/08/2005

Serum Biomarkers for Head & Neck Cancer (deidentified)

Basic Science

VICCHN0356

02/04/2003

Head and Neck Tumor Tissue Repository and Clinical Database

Other

VICCHN14122

12/23/2014

A Pilot Study for a Pain Management Smartphone Application for Patients Undergoing Radiation Therapy for Locally Advanced Head and Neck Cancer

Other

VICCSUPP1224

11/19/2012

Osteonecrosis of the Jaw Case (ONJ) Registry

Other

VICCTHN1293

10/23/2012

Comparative Musculoskeletal Impairment in Patients with Head and Neck Cancer Undergoing Surgical Reconstruction with Pectoralis Major Myocutaneous Flap Vs Revascularized Free Tissue Transfer

Supportive Care

VICCSUPP1282

08/23/2013

Feasibility and Preliminary Efficacy of Hatha Yoga in Head and Neck Cancer Survivors

Treatment

VICCHN1464

11/14/2014

A Phase 2, Open-label Study of the Safety and Efficacy of the Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) in Patients with Advanced Squamous Cell Carcinoma of the Head and Neck, Lung or Esophagus.

Treatment

ECOGHNE3311

08/29/2014

Phase II Randomized Trial of Transoral Surgical Resection Followed by Low-Dose or Standard-Dose IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer

Treatment

VICCHN1433

07/16/2014

An Open Label, Randomized Phase 3 Clinical Trial of Nivolumab vs Therapy of Investigator's Choice in Recurrent or Metastatic Platinum-refractory Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Treatment

VICCTHN1340

10/14/2013

A Phase II Study of Carboplatin, Nab-Paclitaxel and Cetuximab for Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Treatment

VICCMD1188

06/08/2012

An Open-Label, Phase II Study of Vemurafenib in Patients with BRAF V600 Mutation-Positive Cancers

Treatment

ECOGHNE1305-M

02/11/2009

A Phase III Randomized Trial of Chemotherapy with or without Bevacizumab in Patients with Recurrent or Metastatic Head and Neck Cancer